Switching to the neuspera bladder leak device
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is for people who already have a sacral neuromodulation (SNM) device for bladder leakage and want to switch to a newer, upgraded Neuspera system. It will track how well the new device works and how patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a traditional sacral neuromodulation (SNM) device and want to switch to the new Neuspera system, or you had one removed in the past year.
- You are 22 years of age or older.
- You have documented at least 50% improvement in leakage episodes (urgent urinary incontinence) on a bladder diary, either during a trial or with your current system.
- You are healthy enough for surgery and can receive the Neuspera system per its instructions.
- You can attend all required testing and follow-up visits.
- You cannot be enrolled in another investigational drug or device trial during this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that stimulates the sacral nerve (a nerve in your lower back that controls the bladder) for just 30 minutes. It may help reduce sudden, strong urges to urinate that cause leakage, without the need for daily medications.
This study checks how well a device that uses mild electrical pulses to manage bladder urgency works over time. If you completed an earlier study for this device, you may be able to join and help doctors learn more about its long-term benefits.
This study tests a new version of a sacral nerve stimulation device (Axonics model 5101) for people with overactive bladder. It aims to see if the device is safe and works well to reduce sudden urges and frequent urination.
This study checks how well an implanted pelvic nerve system works for people with bladder overactivity, non-obstructive urinary retention, or fecal incontinence. You may need to keep your current medications steady and track symptoms closely with diaries before and during evaluation.
This study tests how well a short, in-office nerve evaluation (PNE) predicts the success of sacral neuromodulation—a treatment that uses mild electrical pulses to calm bladder nerves. It is for women with urgency leaking or very frequent urination.
This trial is for people with overactive bladder who are already scheduled to receive a nerve stimulator implant (sacral neuromodulation). The study will measure how your body's automatic nervous system responds when the device is turned on, which may help doctors understand how the treatment works.
Hear when a new Urinary Urge Incontinence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.